Table 3: Basic angiographic data and echo findings, treatment provided and interventional data.
Characteristics | Patients (n = 280) | Male (n = 140) | Female (n = 140) |
ECHO | |||
Normal | 176 (62.9%) | 81 (57.9%) | 95(67.9%)3 |
Mild dysfunction | 60 (21.4%) | 35 (25%) | 25 (17.9%) |
Moderate dysfunction | 38 (13.6%) | 20 (14.3%) | 18 (12.9%) |
Severe dysfunction | 6 (2.2%) | 4 (2.8%) | 2 (1.4%) |
Ejection fraction less than 25% | 6 (2.1%) | 4 (2.9%) | 2 (1.4%) |
Mitral regurgitation more than class 3 | 12 (4.3%) | 0 | 12 (8.6%) |
Coronary angiographic findings | |||
TVD | 46 (16.4%) | 20 (14.3%) | 26 (18.6%) |
DVD | 49 (17.5%) | 33 (23.6%) | 16 (11.4%) |
SVD | 67 (23.9%) | 34 (24.3%) | 33 (23.6%) |
LMD | 5 (1.8%) | 1 (0.7%) | 4 (2.9%) |
LMD + DVD | 6 (2.1%) | 6 (4.3%) | 0 |
LMD + TVD | 8 (2.9%) | 4 (2.9%) | 4 (2.9%) |
Mild CAD | 42 (15%) | 16 (11.4%) | 26 (18.6%) |
Normal | 57 (20.4%) | 26 (18.6%) | 31 (22.1%) |
Treatment selected | |||
PCI | 116 (41.4%) | 69 (49.3%) | 47 (33.6%) |
CABG | 43 (15.4%) | 18 (12.9%) | 25 (17.9%) |
Medical | 121 (43.2%) | 53 (37.9%) | 68 (48.6%) |
PCPCI angiographic data | |||
Bare metal stent (BMS) | 18 (15.5%) | 8 (11.6%) | 10 (21.3%) |
Drug eluting stent (DES) | 97 (84.5%) | 61 (88.4%) | 36 (78.7%) |
Failure of PCI | 1 (0.9%) | 0 | 1 (2.1%) |
Bifurcation stenting | 5 (4.3%) | 1 (1.4%) | 4 (8.5%) |
PCI of ISR | 4 (3.4%) | 2 (2.9%) | 2 (4.3%) |
TVD: Triple Vessel Disease; DVD: Double Vessel Disease; SVD: Single Vessel Disease; LM: Left Main; CAD: Coronary Artery Disease; MR: Mitral Regurgitation; EF: Ejection Fraction; PCI: Percutaneous Coronary Intervention; CABG: Coronary Artery Bypass Grafting; BMS: Bare Metal Stent; DES: Drug Eluting Stent; ISR: Instent Restenosis